The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Bankole A. Johnson

Department of Psychiatry

University of Texas Health Science Center

7703 Floyd Curl Dr

Mail Stop 7792



Name/email consistency: high



  • Department of Psychiatry, University of Texas Health Science Center, 7703 Floyd Curl Dr, Mail Stop 7792, USA. 2000 - 2005
  • University of Texas, Health Science Center at San Antonio, 78284-7792, USA. 1999 - 2004
  • Department of Psychiatry, Division of Alcohol and Drug Addiction, The University of Texas Health Science Center at San Antonio, South Texas Addiction Research and Technology (START) Center, USA. 2004
  • Division of Alcohol and Drug Addiction, Department of Psychiatry, The University of Texas Health Science Center at San Antonio, 3939 Medical Drive, USA. 2004
  • Department of Psychiatry, University of Texas, San Antonio, USA. 2000


  1. Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Wallace, C., Wells, L.T., Wang, Y. Psychopharmacology (Berl.) (2005) [Pubmed]
  2. Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics. Johnson, B.A., Swift, R.M., Ait-Daoud, N., DiClemente, C.C., Javors, M.A., Malcolm, R.J. Alcohol. Clin. Exp. Res. (2004) [Pubmed]
  3. Effects of isradipine on cocaine-induced subjective mood. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Wells, L.T., Mauldin, J.B. J. Clin. Psychopharmacol (2004) [Pubmed]
  4. Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study. Johnson, B.A. Alcohol. Clin. Exp. Res. (2004) [Pubmed]
  5. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Johnson, B.A. Expert. Opin. Pharmacother (2004) [Pubmed]
  6. Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?. Johnson, B.A. Addict. Behav (2004) [Pubmed]
  7. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Johnson, B.A., Ait-Daoud, N., Akhtar, F.Z., Ma, J.Z. Arch. Gen. Psychiatry (2004) [Pubmed]
  8. A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence. Johnson, B.A., Ait-Daoud, N., Aubin, H.J., Van Den Brink, W., Guzzetta, R., Loewy, J., Silverman, B., Ehrich, E. Alcohol. Clin. Exp. Res. (2004) [Pubmed]
  9. Uses of topiramate in the treatment of alcohol dependence. Johnson, B.A. Expert. Rev. Neurother (2004) [Pubmed]
  10. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Johnson, B.A., Ait-Daoud, N., Bowden, C.L., DiClemente, C.C., Roache, J.D., Lawson, K., Javors, M.A., Ma, J.Z. Lancet (2003) [Pubmed]
  11. Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Johnson, B.A., O'Malley, S.S., Ciraulo, D.A., Roache, J.D., Chambers, R.A., Sarid-Segal, O., Couper, D. J. Clin. Psychopharmacol (2003) [Pubmed]
  12. The role of serotonergic agents as treatments for alcoholism. Johnson, B.A. Drugs. Today (2003) [Pubmed]
  13. Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals. Johnson, B.A., Ait-Daoud, N., Ma, J.Z., Wang, Y. Alcohol. Clin. Exp. Res. (2003) [Pubmed]
  14. Ondansetron reduces the craving of biologically predisposed alcoholics. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Zanca, N.A., Velazquez, M. Psychopharmacology (Berl.) (2002) [Pubmed]
  15. Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists. Johnson, B.A., Devous, M.D., Ruiz, P., Ait-Daoud, N. Am. J. Psychiatry (2001) [Pubmed]
  16. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. Johnson, B.A., Ait-Daoud, N., Prihoda, T.J. Alcohol. Clin. Exp. Res. (2000) [Pubmed]
  17. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Johnson, B.A., Ait-Daoud, N. Psychopharmacology (Berl.) (2000) [Pubmed]
  18. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. Johnson, B.A., Roache, J.D., Javors, M.A., DiClemente, C.C., Cloninger, C.R., Prihoda, T.J., Bordnick, P.S., Ait-Daoud, N., Hensler, J. JAMA (2000) [Pubmed]
  19. Serotonergic agents and alcoholism treatment: rebirth of the subtype concept--an hypothesis. Johnson, B.A. Alcohol. Clin. Exp. Res. (2000) [Pubmed]
  20. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study. Johnson, B.A., Roache, J.D., Bordnick, P.S., Ait-Daoud, N. Psychopharmacology (Berl.) (1999) [Pubmed]
  21. Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced reduction in hunger. Johnson, B.A., Ait-Daoud, N., Bordnick, P.S. Prog. Neuropsychopharmacol. Biol. Psychiatry (1999) [Pubmed]
WikiGenes - Universities